MARKET

LUNG

LUNG

Pulmonx Corp
NASDAQ
1.550
+0.010
+0.65%
After Hours: 1.550 0 0.00% 16:10 05/22 EDT
OPEN
1.550
PREV CLOSE
1.540
HIGH
1.629
LOW
1.540
VOLUME
309.83K
TURNOVER
--
52 WEEK HIGH
3.880
52 WEEK LOW
1.130
MARKET CAP
65.47M
P/E (TTM)
-1.1980
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at LUNG last week (0511-0515)?
Weekly Report · 4d ago
Weekly Report: what happened at LUNG last week (0504-0508)?
Weekly Report · 05/11 10:34
Pulmonx publishes investor presentation on Zephyr valves for severe emphysema treatment
PUBT · 05/05 05:52
Weekly Report: what happened at LUNG last week (0427-0501)?
Weekly Report · 05/04 10:30
Pulmonx Earnings Call: Margin Gains Amid Growth Pause
TipRanks · 05/01 00:58
Lake Street Remains a Buy on Pulmonx (LUNG)
TipRanks · 04/30 16:36
Pulmonx (LUNG) Q1 2026 Earnings Transcript
The Motley Fool · 04/30 16:25
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), AbCellera Biologics (ABCL) and Pulmonx (LUNG)
TipRanks · 04/30 15:31
More
About LUNG
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The Company’s Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, and StratX Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD. The LungTraX Platform is a cloud-based quantitative CT (QCT) analysis service that provides physicians with multiple products, LungTraX Connect, to improve workup efficiency, LungTraX Detect, to enable patient identification and an easy-to-read StratX Lung report that it designed for its solution that includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a proprietary balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation.

Webull offers Pulmonx Corp stock information, including NASDAQ: LUNG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LUNG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LUNG stock methods without spending real money on the virtual paper trading platform.